Use of limited sampling strategy to evaluate the relationship between pharmacokinetics and farmacogenetics of the anticancer drugs Docetaxel (Taxotere) and Paclitaxel (Taxol).

Trial Profile

Use of limited sampling strategy to evaluate the relationship between pharmacokinetics and farmacogenetics of the anticancer drugs Docetaxel (Taxotere) and Paclitaxel (Taxol).

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 May 2010

At a glance

  • Drugs Docetaxel (Primary) ; Paclitaxel (Primary)
  • Indications Cancer
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 18 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top